Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Review of the microscopic colitides.

Current gastroenterology reports

Yen EF, Pardi DS.
PMID: 21773709
Curr Gastroenterol Rep. 2011 Oct;13(5):458-64. doi: 10.1007/s11894-011-0207-7.

Microscopic colitis is a common cause of chronic diarrhea in predominantly older adults. Incidence rates of microscopic colitis (including lymphocytic and collagenous colitis) have increased over time to levels comparable to other forms of inflammatory bowel disease. The possibility...

Cite
Yen EF, Pardi DS. Review of the microscopic colitides. Curr Gastroenterol Rep. 2011;13(5):458-64doi: 10.1007/s11894-011-0207-7.
Yen, E. F., & Pardi, D. S. (2011). Review of the microscopic colitides. Current gastroenterology reports, 13(5), 458-64. https://doi.org/10.1007/s11894-011-0207-7
Yen, Eugene F, and Pardi, Darrell S. "Review of the microscopic colitides." Current gastroenterology reports vol. 13,5 (2011): 458-64. doi: https://doi.org/10.1007/s11894-011-0207-7
Yen EF, Pardi DS. Review of the microscopic colitides. Curr Gastroenterol Rep. 2011 Oct;13(5):458-64. doi: 10.1007/s11894-011-0207-7. PMID: 21773709.
Copy Download .nbib Format: NLM
[Possibilities and limits in the treatment of uncomplicated diarrhea].

Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis

[No authors listed]
PMID: 2884176
Fortschr Med Suppl. 1987;28:1-23.

No abstract available.

Cite
Möglichkeiten und Grenzen in der Therapie der unkomplizierten Diarrhöe. [Possibilities and limits in the treatment of uncomplicated diarrhea]. Fortschr Med Suppl. 1987;28:1-23
(1987). Möglichkeiten und Grenzen in der Therapie der unkomplizierten Diarrhöe. [Possibilities and limits in the treatment of uncomplicated diarrhea]. Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis, 281-23.
"Möglichkeiten und Grenzen in der Therapie der unkomplizierten Diarrhöe." [Possibilities and limits in the treatment of uncomplicated diarrhea]. Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis vol. 28 (1987): 1-23.
Möglichkeiten und Grenzen in der Therapie der unkomplizierten Diarrhöe. [Possibilities and limits in the treatment of uncomplicated diarrhea]. Fortschr Med Suppl. 1987;28:1-23. German. PMID: 2884176.
Copy Download .nbib Format: NLM
Interventions for treating collagenous colitis.

The Cochrane database of systematic reviews

Chande N, McDonald JW, Macdonald JK.
PMID: 18425892
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003575. doi: 10.1002/14651858.CD003575.pub5.

BACKGROUND: Collagenous colitis is a cause of chronic diarrhea. Treatment has been based mainly on anecdotal evidence. This review was performed to identify therapies for collagenous colitis that have been proven in randomized trials.OBJECTIVES: To determine effective treatments for...

Cite
Chande N, McDonald JW, Macdonald JK. Interventions for treating collagenous colitis. Cochrane Database Syst Rev. 2008;(2):CD003575doi: 10.1002/14651858.CD003575.pub5.
Chande, N., McDonald, J. W., & Macdonald, J. K. (2008). Interventions for treating collagenous colitis. The Cochrane database of systematic reviews, (2), CD003575. https://doi.org/10.1002/14651858.CD003575.pub5
Chande, N, et al. "Interventions for treating collagenous colitis." The Cochrane database of systematic reviews vol. ,2 (2008): CD003575. doi: https://doi.org/10.1002/14651858.CD003575.pub5
Chande N, McDonald JW, Macdonald JK. Interventions for treating collagenous colitis. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003575. doi: 10.1002/14651858.CD003575.pub5. PMID: 18425892.
Copy Download .nbib Format: NLM
Persistent diarrhea: still an important challenge for the pediatrician.

Jornal de pediatria

Andrade JA, Fagundes-Neto U.
PMID: 21660370
J Pediatr (Rio J). 2011 May-Jun 8;87(3):199-205. doi: 10.2223/JPED.2087.

OBJECTIVE: To provide recent guidelines to reduce the incidence of diarrheal diseases. We discuss the definition, clinical aspects, pathophysiology, diagnosis, management, and prevention of persistent diarrhea.SOURCES: Electronic search of the MEDLINE database, Google search.SUMMARY OF THE FINDINGS: Acute diarrhea...

Cite
Andrade JA, Fagundes-Neto U. Persistent diarrhea: still an important challenge for the pediatrician. J Pediatr (Rio J). 2011;87(3):199-205doi: 10.2223/JPED.2087.
Andrade, J. A., & Fagundes-Neto, U. (2011). Persistent diarrhea: still an important challenge for the pediatrician. Jornal de pediatria, 87(3), 199-205. https://doi.org/10.2223/JPED.2087
Andrade, Jacy Alves Braga de, and Fagundes-Neto, Ulysses. "Persistent diarrhea: still an important challenge for the pediatrician." Jornal de pediatria vol. 87,3 (2011): 199-205. doi: https://doi.org/10.2223/JPED.2087
Andrade JA, Fagundes-Neto U. Persistent diarrhea: still an important challenge for the pediatrician. J Pediatr (Rio J). 2011 May-Jun 8;87(3):199-205. doi: 10.2223/JPED.2087. Portuguese. PMID: 21660370.
Copy Download .nbib Format: NLM
Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Shah SL, Janisch NH, Crowell M, Lacy BE.
PMID: 32289536
Clin Gastroenterol Hepatol. 2021 Jan;19(1):80-86. doi: 10.1016/j.cgh.2020.04.003. Epub 2020 Apr 11.

BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is a common chronic functional bowel disorder for which patients take significant risks to ameliorate symptoms. Unfortunately, there is no cure for IBS. We assessed the willingness of patients with IBS to...

Cite
Shah SL, Janisch NH, Crowell M, et al. Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief. Clin Gastroenterol Hepatol. 2020;19(1):80-86doi: 10.1016/j.cgh.2020.04.003.
Shah, S. L., Janisch, N. H., Crowell, M., & Lacy, B. E. (2021). Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 19(1), 80-86. https://doi.org/10.1016/j.cgh.2020.04.003
Shah, Shawn L, et al. "Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. 19,1 (2021): 80-86. doi: https://doi.org/10.1016/j.cgh.2020.04.003
Shah SL, Janisch NH, Crowell M, Lacy BE. Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief. Clin Gastroenterol Hepatol. 2021 Jan;19(1):80-86. doi: 10.1016/j.cgh.2020.04.003. Epub 2020 Apr 11. PMID: 32289536.
Copy Download .nbib Format: NLM
Advances in the treatment of diarrhoea.

Midwife and health visitor

Cooper P.
PMID: 5206013
Midwife Health Visit. 1970 Jun;6(6):229.

No abstract available.

Cite
Cooper P. Advances in the treatment of diarrhoea. Midwife Health Visit. 1970;6(6):229
Cooper, P. (1970). Advances in the treatment of diarrhoea. Midwife and health visitor, 6(6), 229.
Cooper, P. "Advances in the treatment of diarrhoea." Midwife and health visitor vol. 6,6 (1970): 229.
Cooper P. Advances in the treatment of diarrhoea. Midwife Health Visit. 1970 Jun;6(6):229. PMID: 5206013.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries